Policy changes Backwork has recorded, newest first. The most recent change on record is from October 14, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
83,427 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| Aug 2, 2026 | Point32Health | Pegfilgrastim Products | New policy |
| Aug 2, 2026 | Point32Health | Pediculicide Medications | New policy |
| Aug 2, 2026 | Point32Health | Parkinson’s Disease Medications | New policy |
| Aug 2, 2026 | Point32Health | Parathyroid Hormones | New policy |
| Aug 2, 2026 | Point32Health | Parathyroid Hormone Analogs | New policy |
| Aug 2, 2026 | Point32Health | Pancreatic Enzymes Step Therapy | New policy |
| Aug 2, 2026 | Point32Health | PCSK9 Inhibitors | New policy |
| Aug 2, 2026 | Point32Health | Oxervate (cenegermin-bkbj) | New policy |
| Aug 2, 2026 | Point32Health | Oxervate (cenegermin-bkbj) | New policy |
| Aug 2, 2026 | Point32Health | Overactive Bladder Medications | New policy |
| Aug 2, 2026 | Point32Health | Otezla and Otezla XR | New policy |
| Aug 2, 2026 | Point32Health | Osphena (ospemifene) | New policy |
| Aug 2, 2026 | Point32Health | Orencia (abatacept) Subcutaneous | New policy |
| Aug 2, 2026 | Point32Health | Oral Bisphosphonate Medications (alendronate with vitamin D, risedronate) | New policy |
| Aug 2, 2026 | Point32Health | Oral Antifungal Agents | New policy |
| Aug 2, 2026 | Point32Health | Oral Antifungal Agents | New policy |
| Aug 2, 2026 | Point32Health | Oracea (doxycycline monohydrate 40mg) Step Therapy | New policy |
| Aug 2, 2026 | Point32Health | Opzelura (ruxolitinib) Step Therapy Program | New policy |
| Aug 2, 2026 | Point32Health | Opzelura (ruxolitinib) | New policy |
| Aug 2, 2026 | Point32Health | Opioid Dependence Medications | New policy |
| Aug 2, 2026 | Point32Health | Opioid Analgesics | New policy |
| Aug 2, 2026 | Point32Health | Opioid Analgesics | New policy |
| Aug 2, 2026 | Point32Health | Ophthalmic Corticosteroids | New policy |
| Aug 2, 2026 | Point32Health | Omvoh (mirikizumab-mrkz) Subcutaneous | New policy |
| Aug 2, 2026 | Point32Health | Olumiant (baricitinib) | New policy |
| Aug 2, 2026 | Point32Health | Ohtuvayre (ensifentrine) | New policy |
| Aug 2, 2026 | Point32Health | Ohtuvayre (ensifentrine) | New policy |
| Aug 2, 2026 | Point32Health | Nuzyra (omadacycline) tablets | New policy |
| Aug 2, 2026 | Point32Health | Nuedexta (dextromethorphan/quinidine) | New policy |
| Aug 2, 2026 | Point32Health | Nuedexta (dextromethorphan /quinidine) | New policy |
| Aug 2, 2026 | Point32Health | Nucala (mepolizumab) Pre-filled Autoinjector and Syringe | New policy |
| Aug 2, 2026 | Point32Health | Nucala (mepolizumab) Pre-filled Autoinjector and Syringe | New policy |
| Aug 2, 2026 | Point32Health | Nucala (mepolizumab) Pre-filled Autoinjector and Syringe | New policy |
| Aug 2, 2026 | Point32Health | Nourianz (istradefylline) | New policy |
| Aug 2, 2026 | Point32Health | Northera (droxidopa) | New policy |
| Aug 2, 2026 | Point32Health | Non-Triptan Migraine Medications | New policy |
| Aug 2, 2026 | Point32Health | Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) | New policy |
| Aug 2, 2026 | Point32Health | Non-Sedating Antihistamines | New policy |
| Aug 2, 2026 | Point32Health | Non-Preferred Insulins | New policy |
| Aug 2, 2026 | Point32Health | Non-Opioid Pharmacy Products with Quantity Limitations | New policy |
| Aug 2, 2026 | Point32Health | Non-Hormonal Medications for Menopause | New policy |
| Aug 2, 2026 | Point32Health | Non-Formulary Exceptions | New policy |
| Aug 2, 2026 | Point32Health | Nityr and Orfadin (nitisinone) | New policy |
| Aug 2, 2026 | Point32Health | Nitisinone Products | New policy |
| Aug 2, 2026 | Point32Health | Nexletol (bempedoic acid) and Nexlizet (bempedoic acid/ezetimibe) | New policy |
| Aug 2, 2026 | Point32Health | New-To-Market Drugs | New policy |
| Aug 2, 2026 | Point32Health | Neupro (rotigotine) | New policy |
| Aug 2, 2026 | Point32Health | Nemluvio (nemolizumab-ilto) | New policy |
| Aug 2, 2026 | Point32Health | Nasal Corticosteroid Medications | New policy |
| Aug 2, 2026 | Point32Health | NSAID Combinations | New policy |